top of page

Novilytic Named a 2023 Powderkeg Top 100 Award Winner


A graphic showing Powderkeg's award to Novilytic

WEST LAFAYETTE, Ind. – Novilytic LLC, a molecular-recognition company that uses nanotechnology to monitor the quality of lifesaving medicines, has been announced as a winning company in the 2023 Powderkeg Unvalley Awards. This recognizes Novilytic as one of the best biotech companies to work for in emerging communities beyond Silicon Valley.


The Powderkeg Unvalley Top 100 Awards recognize the best startups and tech companies in emerging tech communities beyond Silicon Valley. Companies in the fastest-growing tech industries were selected based on information submitted to Powderkeg by employees and leadership, supplemented with publicly available third-party data. Companies were able to submit data via their profile on Powderkeg, highlighting company size, perks and benefits, funding, industry, and employee testimonials.


This is the fifth year that Powderkeg has presented awards to recognize tech companies in fast-growing communities beyond Silicon Valley — in the “Unvalley.”


More than seven hundred companies were recognized in each of the following categories:

  • Top 100 Fintech Companies

  • Top 100 SaaS Companies

  • Top 100 Biotech Companies

  • Top 100 Cybersecurity Companies

  • Top 100 Robotics Companies

  • Top 100 Education Technology Companies

  • Top 100 Health Tech Companies

  • Top 100 Tech Companies

Powderkeg announced the award winners on August 29, 2023. The winning companies were recognized at a national level.


With more than 10,000 active members in tech hubs across the US, Powderkeg is the place to plug into tech in the middle of America. Through a robust offering of events, digital media and resources, Powderkeg supports thousands of professionals, employers and teams by creating opportunities to learn and connect.


Learn more about the finalists at powderkeg.com/awards.


###


About Novilytic Novilytic has created the world’s first nanotechnology for at-line molecular structure analysis. Replacing 40-year-old technology, their Proteometer a.k.a. “proteoform meter” is an analytical tool for drug development and clone selection. It allows pharmaceutical companies to streamline their processes and to recognize in near real-time if and when a batch of medication is going awry. This eliminates costly post-purification efforts and helps breakthrough cures reach patients quicker. The technology is backed by multiple patents developed by some of the most brilliant minds in analytical chemistry. Visit Novilytic.com to learn more.


30 views0 comments

コメント


bottom of page